At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LGVN Longeveron Inc
Closed 05-31 16:00:00 EDT
1.10
+0.01
+0.92%
盘后1.12
+0.02+1.82%
19:26 EDT
High1.15
Low1.03
Vol131.54K
Open1.10
D1 Closing1.09
Amplitude11.01%
Mkt Cap6.98M
Tradable Cap4.74M
Total Shares6.35M
T/O144.87K
T/O Rate3.05%
Tradable Shares4.31M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Longeveron® to Attend BIO International Convention 2024
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, a candidate in Phase 2a/b trials that is used for the treatment of alzheimer's disease, hypoplastic left heart syndrome, and aging-related frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.